SEARCH

SEARCH BY CITATION

References

  • Adem, P. V., C. P. Montgomery, A. N. Husain, T. K. Koogler, V. Arangelovich, M. Humilier, et al. 2005. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N. Engl. J. Med. 353:12451251.
  • Bae, T., and O. Schneewind. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:5863.
  • Beasley, F. C., E. D. Vines, J. C. Grigg, Q. Zheng, S. Liu, G. A. Lajoie, et al. 2009. Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol. Microbiol. 72:947963.
  • Beaufort, N., P. Wojciechowski, C. P. Sommerhoff, G. Szmyd, G. Dubin, S. Eick, et al. 2008. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem. J. 410:157165.
  • Borezee-Durant, E., A. Hiron, J. C. Piard, and V. Juillard. 2009. Dual role of the oligopeptide permease Opp 3 during growth of Staphylococcus aureus in milk. Appl. Environ. Microbiol. 75:33553357.
  • Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238250.
  • Bubeck Wardenburg, J., T. Bae, M. Otto, F. R. Deleo, and O. Schneewind. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:14051406.
  • Bunce, C., L. Wheeler, G. Reed, J. Musser, and N. Barg. 1992. Murine model of cutaneous infection with Gram-positive cocci. Infect. Immun. 60:26362640.
  • Burlak, C., C. H. Hammer, M. A. Robinson, A. R. Whitney, M. J. McGavin, B. N. Kreiswirth, et al. 2007. Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell. Microbiol. 9:11721190.
  • Calander, A. M., I. M. Jonsson, A. Kanth, S. Arvidsson, L. Shaw, S. J. Foster, et al. 2004. Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect. 6:202206.
  • Calander, A. M., G. Dubin, J. Potempa, and A. Tarkowski. 2008. Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies. FEMS Immunol. Med. Microbiol. 52:267272.
  • Camargo, I. L., and M. S. Gilmore. 2008. Staphylococcus aureus–probing for host weakness? J. Bacteriol. 190:22532256.
  • Carroll, R. K., T. M. Robison, F. E. Rivera, J. E. Davenport, I. M. Jonsson, D. Florczyk, et al. 2012. Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes Infect. 14:989999.
  • Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, et al. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:35233534.
  • Coulter, S. N., W. R. Schwan, E. Y. Ng, M. H. Langhorne, H. D. Ritchie, S. Westbrock-Wadman, et al. 1998. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30:393404.
  • D'Agata, E. M., G. F. Webb, M. A. Horn, R. C. Jr Moellering, and S. Ruan. 2009. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin. Infect. Dis. 48:274284.
  • Diep, B. A., and M. Otto. 2008. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16:361369.
  • Dumont, A. L., T. K. Nygaard, R. L. Watkins, A. Smith, L. Kozhaya, B. N. Kreiswirth, et al. 2011. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79:814825.
  • Garnier, F., A. Tristan, B. Francois, J. Etienne, M. Delage-Corre, C. Martin, et al. 2006. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg. Infect. Dis. 12:498500.
  • Gatlin, C. L., R. Pieper, S. T. Huang, E. Mongodin, E. Gebregeorgis, P. P. Parmar, et al. 2006. Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 6:15301549.
  • Gonzalez, D. J., C. Y. Okumura, A. Hollands, R. Kersten, K. Akong-Moore, M. A. Pence, et al. 2012. Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J. Biol. Chem. 287:1388913898.
  • Hiron, A., E. Borezee-Durant, J. C. Piard, and V. Juillard. 2007. Only one of four oligopeptide transport systems mediates nitrogen nutrition in Staphylococcus aureus. J. Bacteriol. 189:51195129.
  • Holtfreter, S., T. T. Nguyen, H. Wertheim, L. Steil, H. Kusch, Q. P. Truong, et al. 2009. Human immune proteome in experimental colonization with Staphylococcus aureus. Clin. Vaccine Immunol. 16:16071614.
  • Imamura, T., S. Tanase, G. Szmyd, A. Kozik, J. Travis, and J. Potempa. 2005. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 201:16691676.
  • Johnson, J. K., T. Khoie, S. Shurland, K. Kreisel, O. C. Stine, and M. C. Roghmann. 2007. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg. Infect. Dis. 13:11951200.
  • Kansal, R. G., A. McGeer, D. E. Low, A. Norrby-Teglund, and M. Kotb. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68:63626369.
  • Kansal, R. G., V. Nizet, A. Jeng, W. J. Chuang, and M. Kotb. 2003. Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J. Infect. Dis. 187:398407.
  • Karlsson, A., and S. Arvidson. 2002. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect. Immun. 70:42394246.
  • Karlsson, A., P. Saravia-Otten, K. Tegmark, E. Morfeldt, and S. Arvidson. 2001. Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect. Immun. 69:47424748.
  • Kavanaugh, J. S., M. Thoendel, and A. R. Horswill. 2007. A role for type I signal peptidase in Staphylococcus aureus quorum sensing. Mol. Microbiol. 65:780798.
  • Kobayashi, S. D., and F. R. DeLeo. 2009. An update on community-associated MRSA virulence. Curr. Opin. Pharmacol. 9:545551.
  • Kolar, S. L., V. Nagarajan, A. Oszmiana, F. E. Rivera, H. K. Miller, J. E. Davenport, et al. 2011. NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus. Microbiology 157:22062219.
  • Koprivnjak, T., V. Mlakar, L. Swanson, B. Fournier, A. Peschel, and J. P. Weiss. 2006. Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J. Bacteriol. 188:36223630.
  • Kubica, M., K. Guzik, J. Koziel, M. Zarebski, W. Richter, B. Gajkowska, et al. 2008. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 3:e1409.
  • Laarman, A. J., M. Ruyken, C. L. Malone, J. A. van Strijp, A. R. Horswill, and S. H. Rooijakkers. 2011. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 186:64456453.
  • Laarman, A. J., G. Mijnheer, J. M. Mootz, W. J. van Rooijen, M. Ruyken, C. L. Malone, et al. 2012. Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J. doi:10.1038/emboj.2012.212.
  • Labandeira-Rey, M., F. Couzon, S. Boisset, E. L. Brown, M. Bes, Y. Benito, et al. 2007. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:11301133.
  • Li, M., B. A. Diep, A. E. Villaruz, K. R. Braughton, X. Jiang, F. R. DeLeo, et al. 2009. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 106:58835888.
  • Limbago, B., G. E. Fosheim, V. Schoonover, C. E. Crane, J. Nadle, S. Petit, et al. 2009. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J. Clin. Microbiol. 47:13441351.
  • Lindsay, J. A., and S. J. Foster. 1999. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol. Gen. Genet. 262:323331.
  • Liu, M., J. R. Bayjanov, B. Renckens, A. Nauta, and R. J. Siezen. 2010. The proteolytic system of lactic acid bacteria revisited: a genomic comparison. BMC Genomics 11:36.
  • Loffler, B., M. Hussain, M. Grundmeier, M. Bruck, D. Holzinger, G. Varga, et al. 2010. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6:e1000715.
  • Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520532.
  • Massimi, I., E. Park, K. Rice, W. Muller-Esterl, D. Sauder, and M. J. McGavin. 2002. Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. Chem. 277:4177041777.
  • McAdow, M., H. K. Kim, A. C. Dedent, A. P. Hendrickx, O. Schneewind, and D. M. Missiakas. 2011. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 7:e1002307.
  • McAleese, F. M., E. J. Walsh, M. Sieprawska, J. Potempa, and T. J. Foster. 2001. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J. Biol. Chem. 276:2996929978.
  • McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:51135120.
  • McGavin, M. J., C. Zahradka, K. Rice, and J. E. Scott. 1997. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect. Immun. 65:26212628.
  • Miller, H. K., R. K. Carroll, W. N. Burda, C. N. Krute, J. E. Davenport, and L. N. Shaw. 2012. The Extracytoplasmic Function Sigma Factor sigmaS Protects against both Intracellular and Extracytoplasmic Stresses in Staphylococcus aureus. J. Bacteriol. 194:43424354.
  • Montgomery, C. P., S. Boyle-Vavra, P. V. Adem, J. C. Lee, A. N. Husain, J. Clasen, et al. 2008. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J. Infect. Dis. 198:561570.
  • Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666674.
  • Morgan, M. 2005. Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia. BMJ 331:793794.
  • Morinaga, N., Y. Kaihou, and M. Noda. 2003. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol. Immunol. 47:8190.
  • Novick, R. P. 2006. Staphylococcal Pathogenesis and Pathogenicity Factors: Genetics and regulation. Pp. 496516 in V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy and J. I. Rood, eds. Gram-positive pathogens. ASM Press, Washington, DC.
  • Oogai, Y., M. Matsuo, M. Hashimoto, F. Kato, M. Sugai, and H. Komatsuzawa. 2011. Expression of virulence factors by Staphylococcus aureus grown in serum. Appl. Environ. Microbiol. 77:80978105.
  • Popovich, K. J., R. A. Weinstein, and B. Hota. 2008. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46:787794.
  • Potempa, J., W. Watorek, and J. Travis. 1986. The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261:1433014334.
  • Potempa, J., A. Dubin, G. Korzus, and J. Travis. 1988. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 263:26642667.
  • Prajsnar, T. K., V. T. Cunliffe, S. J. Foster, and S. A. Renshaw. 2008. A novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell. Microbiol. 10:23122325.
  • Prokesova, L., B. Potuznikova, J. Potempa, J. Zikan, J. Radl, L. Hachova, et al. 1992. Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol. Lett. 31:259265.
  • Reed, S. B., C. A. Wesson, L. E. Liou, W. R. Trumble, P. M. Schlievert, G. A. Bohach, et al. 2001. Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect. Immun. 69:15211527.
  • Rice, K., R. Peralta, D. Bast, J. de Azavedo, and M. J. McGavin. 2001. Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect. Immun. 69:159169.
  • Rivera, F. E., H. K. Miller, S. L. Kolar, S. M. Jr Stevens, and L. N. Shaw. 2012. The impact of CodY on virulence determinant production in community-associated methicillin-resistant Staphylococcus aureus. Proteomics 12:263268.
  • Shaw, L., E. Golonka, J. Potempa, and S. J. Foster. 2004. The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150:217228.
  • Shaw, L. N., C. Lindholm, T. K. Prajsnar, H. K. Miller, M. C. Brown, E. Golonka, et al. 2008. Identification and characterization of sigmaS, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS ONE 3:e3844.
  • Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, et al. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:46734679.
  • Siezen, R. J. 1999. Multi-domain, cell-envelope proteinases of lactic acid bacteria. Antonie Van Leeuwenhoek 76:139155.
  • Sifri, C. D., J. Begun, F. M. Ausubel, and S. B. Calderwood. 2003. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71:22082217.
  • Smagur, J., K. Guzik, M. Bzowska, M. Kuzak, M. Zarebski, T. Kantyka, et al. 2009a. Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol. Chem. 390:361371.
  • Smagur, J., K. Guzik, L. Magiera, M. Bzowska, M. Gruca, I. B. Thogersen, et al. 2009b. A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by Staphopain B in human neutrophils and monocytes. J. Innate Immun. 1:98108.
  • Tenover, F. C., S. McAllister, G. Fosheim, L. K. McDougal, R. B. Carey, B. Limbago, et al. 2008. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J. Clin. Microbiol. 46:28372841.
  • Thurlow, L. R., G. S. Joshi, and A. R. Richardson. 2012. Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). FEMS Immunol. Med. Microbiol. 65:522.
  • Travis, J., J. Potempa, and H. Maeda. 1995. Are bacterial proteinases pathogenic factors? Trends Microbiol. 3:405407.
  • Voyich, J. M., M. Otto, B. Mathema, K. R. Braughton, A. R. Whitney, D. Welty, et al. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194:17611770.
  • Wang, R., K. R. Braughton, D. Kretschmer, T. H. Bach, S. Y. Queck, M. Li, et al. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13:15101514.
  • Webb, G. F., M. A. Horn, E. M. D'Agata, R. C. Moellering, and S. Ruan. 2009. Competition of hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus strains in hospitals. J. Biol. Dyn. 48:271.
  • Wegrzynowicz, Z., P. B. Heczko, G. R. Drapeau, J. Jeljaszewicz, and G. Pulverer. 1980. Prothrombin activation by a metalloprotease from Staphylococcus aureus. J. Clin. Microbiol. 12:138139.
  • Wiltshire, M. D., and S. J. Foster. 2001. Identification and analysis of Staphylococcus aureus components expressed by a model system of growth in serum. Infect. Immun. 69:51985202.
  • Wormann, M. E., N. T. Reichmann, C. L. Malone, A. R. Horswill, and A. Grundling. 2011. Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J. Bacteriol. 193:52795291.
  • Zielinska, A. K., K. E. Beenken, H. S. Joo, L. N. Mrak, L. M. Griffin, T. T. Luong, et al. 2011. Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J. Bacteriol. 193:29482958.